Antenatal Corticosteroids Prior to 24 Weeks' Gestation and Neonatal Outcome of Extremely Low Birth Weight Infants

ABSTRACT

We sought to determine if antenatal corticosteroid treatment administered prior to 24 weeks' gestation influences neonatal morbidity and mortality in extremely low-birth-weight infants. A retrospective review was performed of all singleton pregnancies treated with one complete course of antenatal corticosteroids prior to 24 weeks' gestation and delivered between 23⁰/₇ and 25⁶/₇ weeks. These infants were compared with similar gestational-age controls. There were no differences in gender, race, birth weight, and gestational age between the groups. Infants exposed to antenatal corticosteroids had lower mortality (29.3% versus 62.9%, p = 0.001) and grade 3 or 4 intraventricular hemorrhage (IVH; 16.7% versus 36%, p < 0.05; relative risk [RR]: 2.16). Grade 3 and 4 IVH was associated with significantly lower survival probability as compared with no IVH or grade 1 and 2 IVH (p < 0.001, RR: 10.6, 95% confidence interval [CI]: 4.4 to 25.6). Antenatal steroid exposure was associated with a 62% decrease in the hazard rate compare with those who did not receive antenatal steroids after adjusting for IVH grade (Cox proportional hazard model, hazard ratio 0.38, 95% CI: 0.152 to 0.957, p = 0.04). The rates of premature rupture of membranes and chorioamnionitis were higher for infants exposed to antenatal corticosteroids. Exposure to a single course of antenatal corticosteroids prior to 24 weeks' gestation was associated with reduction of the risk of severe IVH and neonatal mortality for extremely low-birth-weight infants.

KEYWORDS

Antenatal steroids - extremely low-birth-weight infants - neonatal outcomes

REFERENCES

• 1 Crowley P. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994.  Am J Obstet Gynecol. 1995;  173 322-335
• 2 Liggins G C, Howie R N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.  Pediatrics. 1972;  50 515-525
• 3 Ment L, Ehrenkranz R A, Philip A G, Duncan C C, Makuch R W. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants.  Am J Obstet Gynecol. 1995;  172 795-800
• 4 Shankaran S, Bauer C R, Bain R, Wright L L, Zachary J. Relationship between antenatal steroid administration and grades III and IV intracranial hemorrhage in low birth weight infants.  Am J Obstet Gynecol. 1995;  173 305-312
• 5 Wright L L, Verter J, Younes N for the National Institute of Child Health and Human Development Neonatal Research Network et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants.  Am J Obstet Gynecol. 1995;  173 269-274
• 6 NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes . Effect of corticosteroids for fetal maturation on perinatal outcomes.  JAMA. 1995;  273 413-418
• 7 Papile L A, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birthweight less than 500 g.  J Pediatr. 1978;  92 529-534
• 8 Hayes J H, Paul D A, Stahl G E et al.. Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation.  Am J Obstet Gynecol. 2008;  111 921-923
• 9 Leviton A, Kuban K C, Pagano M, Alred E N, VanMarter L J. Antenatal corticosteroids appear to reduce the risk of germinal matrix hemorrhage in intubated low birth weight newborns.  Pediatrics. 1993;  91 1083-1088
• 10 Jobe A H, Mitchell B R, Gunkel J H. Beneficial effects of combined use of prenatal corticosteroid and postnatal surfactant on preterm infants.  Am J Obstet Gynecol. 1993;  168 508-513
• 11 Wright L L, Horbar J D, Gunkel H. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants.  Am J Obstet Gynecol. 1995;  173 263-269
• 12 Stein H M, Oyama K, Martinez A et al.. Effects of corticosteroids in preterm sheep on adaptation and sympathoadrenal mechanisms at birth.  Am J Physiol. 1993;  264(5 Pt 1) E763-E769
• 13 Sehdev H M, Abbasi S, Robertson P et al.. The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infants.  Am J Obstet Gynecol. 2004;  191 1409-1413
• 14 Abbasi S, Hirsch D, Davis J et al.. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome.  Am J Obstet Gynecol. 2000;  182 1243-1249
• 15 Quist-Therson E C, Ola E, Amankwah K, Ohisson A. Dexamethasone levels in mother and infant(s) after prenatal steroid therapy.  , (abstract) Pediatr Res. 1998;  43 190A
• 16 Eichenwald E C, Stark A R. Management and outcomes of very low birth weight infants.  N Engl J Med. 2008;  358 1700-1711